Back to search results

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Uveal Melanoma · Metastatic Uveal Melanoma · Metastatic Uveal Melanoma in the Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia

    Contact: Study coordinator (Robert Kent) · SVHS.CancerResearch@svha.org.au · 0293555611

  • Alfred Hospital, Melbourne, Victoria, Australia

    Contact: Study coordinator (Mark Shackleton, MBBS PhD)
Study leads

  • Anthony Joshua, FRACP

    Principal Investigator

    St Vincent's Hospital, Sydney

View source on ClinicalTrials.gov(opens in a new tab)